Beta Bionics, Inc. (BBNX) Gross Profit (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Gross Profit data on file, last reported at $16.4 million in Q1 2026.

• Quarterly Gross Profit rose 83.22% year-over-year to $16.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.0 million (up 67.3% YoY) and the FY2025 annual result came in at $55.5 million, up 54.75% from the prior year.
• Gross Profit fell to $16.4 million in Q1 2026 per BBNX's latest filing, from $18.9 million in the prior quarter.
• The five-year high for Gross Profit was $18.9 million in Q4 2025, with the low at $7.2 million in Q1 2024.
• Average Gross Profit over 3 years is $12.0 million, with a median of $11.7 million recorded in 2024.
• Year-over-year, Gross Profit grew 24.58% in 2025 and jumped 83.22% in 2026.
• Beta Bionics' Gross Profit stood at $11.7 million in 2024, then surged by 62.07% to $18.9 million in 2025, then declined by 13.23% to $16.4 million in 2026.
• Business Quant data shows BBNX's Gross Profit at $16.4 million in Q1 2026, $18.9 million in Q4 2025, and $15.1 million in Q3 2025.